Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines
Peptide-major histocompatibility complex class II (pMHCII)-based nanomedicines displaying tissue-specific autoantigenic epitopes can blunt specific autoimmune conditions by re-programming cognate antigen-experienced CD4+ T-cells into disease-suppressing T-regulatory type 1 (TR1) cells. Here, we show...
Saved in:
Published in | Nature communications Vol. 10; no. 1; pp. 2150 - 17 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Nature Publishing Group
14.05.2019
Nature Publishing Group UK Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Peptide-major histocompatibility complex class II (pMHCII)-based nanomedicines displaying tissue-specific autoantigenic epitopes can blunt specific autoimmune conditions by re-programming cognate antigen-experienced CD4+ T-cells into disease-suppressing T-regulatory type 1 (TR1) cells. Here, we show that single pMHCII-based nanomedicines displaying epitopes from mitochondrial, endoplasmic reticulum or cytoplasmic antigens associated with primary biliary cholangitis (PBC) or autoimmune hepatitis (AIH) can broadly blunt PBC, AIH and Primary Sclerosing Cholangitis in various murine models in an organ- rather than disease-specific manner, without suppressing general or local immunity against infection or metastatic tumors. Therapeutic activity is associated with cognate TR1 cell formation and expansion, TR1 cell recruitment to the liver and draining lymph nodes, local B-regulatory cell formation and profound suppression of the pro-inflammatory capacity of liver and liver-proximal myeloid dendritic cells and Kupffer cells. Thus, autoreactivity against liver-enriched autoantigens in liver autoimmunity is not disease-specific and can be harnessed to treat various liver autoimmune diseases broadly. |
---|---|
AbstractList | Peptide-major histocompatibility complex class II (pMHCII)-based nanomedicines displaying tissue-specific autoantigenic epitopes can blunt specific autoimmune conditions by re-programming cognate antigen-experienced CD4+ T-cells into disease-suppressing T-regulatory type 1 (TR1) cells. Here, we show that single pMHCII-based nanomedicines displaying epitopes from mitochondrial, endoplasmic reticulum or cytoplasmic antigens associated with primary biliary cholangitis (PBC) or autoimmune hepatitis (AIH) can broadly blunt PBC, AIH and Primary Sclerosing Cholangitis in various murine models in an organ- rather than disease-specific manner, without suppressing general or local immunity against infection or metastatic tumors. Therapeutic activity is associated with cognate TR1 cell formation and expansion, TR1 cell recruitment to the liver and draining lymph nodes, local B-regulatory cell formation and profound suppression of the pro-inflammatory capacity of liver and liver-proximal myeloid dendritic cells and Kupffer cells. Thus, autoreactivity against liver-enriched autoantigens in liver autoimmunity is not disease-specific and can be harnessed to treat various liver autoimmune diseases broadly.
Immune response against tissue-specific antigens is a hallmark of autoimmunity. Here the authors show that a single autoantigen-based nanomedicine can ameliorate pathology in a broad range of liver autoimmunity models without impairing host defenses, suggesting organ-wide tolerization. Abstract Peptide-major histocompatibility complex class II (pMHCII)-based nanomedicines displaying tissue-specific autoantigenic epitopes can blunt specific autoimmune conditions by re-programming cognate antigen-experienced CD4+ T-cells into disease-suppressing T-regulatory type 1 (TR1) cells. Here, we show that single pMHCII-based nanomedicines displaying epitopes from mitochondrial, endoplasmic reticulum or cytoplasmic antigens associated with primary biliary cholangitis (PBC) or autoimmune hepatitis (AIH) can broadly blunt PBC, AIH and Primary Sclerosing Cholangitis in various murine models in an organ- rather than disease-specific manner, without suppressing general or local immunity against infection or metastatic tumors. Therapeutic activity is associated with cognate TR1 cell formation and expansion, TR1 cell recruitment to the liver and draining lymph nodes, local B-regulatory cell formation and profound suppression of the pro-inflammatory capacity of liver and liver-proximal myeloid dendritic cells and Kupffer cells. Thus, autoreactivity against liver-enriched autoantigens in liver autoimmunity is not disease-specific and can be harnessed to treat various liver autoimmune diseases broadly. Immune response against tissue-specific antigens is a hallmark of autoimmunity. Here the authors show that a single autoantigen-based nanomedicine can ameliorate pathology in a broad range of liver autoimmunity models without impairing host defenses, suggesting organ-wide tolerization. Peptide-major histocompatibility complex class II (pMHCII)-based nanomedicines displaying tissue-specific autoantigenic epitopes can blunt specific autoimmune conditions by re-programming cognate antigen-experienced CD4+ T-cells into disease-suppressing T-regulatory type 1 (TR1) cells. Here, we show that single pMHCII-based nanomedicines displaying epitopes from mitochondrial, endoplasmic reticulum or cytoplasmic antigens associated with primary biliary cholangitis (PBC) or autoimmune hepatitis (AIH) can broadly blunt PBC, AIH and Primary Sclerosing Cholangitis in various murine models in an organ- rather than disease-specific manner, without suppressing general or local immunity against infection or metastatic tumors. Therapeutic activity is associated with cognate TR1 cell formation and expansion, TR1 cell recruitment to the liver and draining lymph nodes, local B-regulatory cell formation and profound suppression of the pro-inflammatory capacity of liver and liver-proximal myeloid dendritic cells and Kupffer cells. Thus, autoreactivity against liver-enriched autoantigens in liver autoimmunity is not disease-specific and can be harnessed to treat various liver autoimmune diseases broadly. Peptide-major histocompatibility complex class II (pMHCII)-based nanomedicines displaying tissue-specific autoantigenic epitopes can blunt specific autoimmune conditions by re-programming cognate antigen-experienced CD4+ T-cells into disease-suppressing T-regulatory type 1 (TR1) cells. Here, we show that single pMHCII-based nanomedicines displaying epitopes from mitochondrial, endoplasmic reticulum or cytoplasmic antigens associated with primary biliary cholangitis (PBC) or autoimmune hepatitis (AIH) can broadly blunt PBC, AIH and Primary Sclerosing Cholangitis in various murine models in an organ- rather than disease-specific manner, without suppressing general or local immunity against infection or metastatic tumors. Therapeutic activity is associated with cognate TR1 cell formation and expansion, TR1 cell recruitment to the liver and draining lymph nodes, local B-regulatory cell formation and profound suppression of the pro-inflammatory capacity of liver and liver-proximal myeloid dendritic cells and Kupffer cells. Thus, autoreactivity against liver-enriched autoantigens in liver autoimmunity is not disease-specific and can be harnessed to treat various liver autoimmune diseases broadly.Immune response against tissue-specific antigens is a hallmark of autoimmunity. Here the authors show that a single autoantigen-based nanomedicine can ameliorate pathology in a broad range of liver autoimmunity models without impairing host defenses, suggesting organ-wide tolerization. |
ArticleNumber | 2150 |
Author | Yamanouchi, Jun Shao, Kun Nanjundappa, Roopa Hebbandi Umeshappa, Channakeshava Sokke Blanco, Jesus Santamaria, Pere Parés, Albert Serra, Pau Yang, Yang Singha, Santiswarup |
Author_xml | – sequence: 1 givenname: Channakeshava Sokke orcidid: 0000-0002-9867-2141 surname: Umeshappa fullname: Umeshappa, Channakeshava Sokke organization: Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada – sequence: 2 givenname: Santiswarup surname: Singha fullname: Singha, Santiswarup organization: Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada – sequence: 3 givenname: Jesus surname: Blanco fullname: Blanco, Jesus organization: Institut D'Investigacions Biomèdiques August Pi i Sunyer, 08036, Barcelona, Spain – sequence: 4 givenname: Kun surname: Shao fullname: Shao, Kun organization: Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada – sequence: 5 givenname: Roopa Hebbandi surname: Nanjundappa fullname: Nanjundappa, Roopa Hebbandi organization: Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada – sequence: 6 givenname: Jun surname: Yamanouchi fullname: Yamanouchi, Jun organization: Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada – sequence: 7 givenname: Albert orcidid: 0000-0002-5413-9687 surname: Parés fullname: Parés, Albert organization: Liver Unit, Hospital Clinic de Barcelona, CIBERehd and University of Barcelona, 08036, Barcelona, Spain – sequence: 8 givenname: Pau surname: Serra fullname: Serra, Pau organization: Institut D'Investigacions Biomèdiques August Pi i Sunyer, 08036, Barcelona, Spain – sequence: 9 givenname: Yang surname: Yang fullname: Yang, Yang organization: Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada – sequence: 10 givenname: Pere surname: Santamaria fullname: Santamaria, Pere email: psantama@ucalgary.ca, psantama@ucalgary.ca organization: Institut D'Investigacions Biomèdiques August Pi i Sunyer, 08036, Barcelona, Spain. psantama@ucalgary.ca |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31089130$$D View this record in MEDLINE/PubMed |
BookMark | eNpVUU1P3DAQtSqqQil_gAOK1HPa8VdiXypVKyhIVD2Uu-XEk8WrxE7tBIl_j9mlCHwZ683MezPzPpOjEAMSck7hGwWuvmdBRdPWQHUNWmleyw_khIGgNW0ZP3rzPyZnOe-gPK6pEuITOeYUlKYcToj_u85zwpx9DFUcKlt1KVpX5Rn7Ja3TMzb6B0yVXZfop2kNWM12uY9j3HrMVfdYZR-2Y0FxXrzD-vf1pu5sRlcFG-KEzvc-YP5CPg52zHj2Ek_J3dXl3ea6vv3z62bz87buZcOWmkMjOoYCsQGpBWMKlNQcJVeDQ2kdgpTONj2AamlrVSeh6RCE0DCUO5ySmwOti3Zn5uQnmx5NtN7sgZi2xqbF9yMaJ3WrpUKmdSsEUx3uxToYnOiht4Xrx4FrXruyR49hSXZ8R_o-E_y92cYH00ja8v0wX18IUvy3Yl7MLq4plPUNY0xSVuR5qWKHqj7FnBMOrwoUzLPZ5mC2KWabvdlGlqaLt7O9tvy3lj8BcHunRQ |
CitedBy_id | crossref_primary_10_3389_fimmu_2020_621774 crossref_primary_10_1016_j_jaut_2021_102619 crossref_primary_10_1016_j_addr_2021_113898 crossref_primary_10_3389_fimmu_2024_1386160 crossref_primary_10_1039_D0BM01171A crossref_primary_10_1016_j_jconrel_2021_08_043 crossref_primary_10_1016_j_imlet_2022_02_007 crossref_primary_10_3390_ijms21051598 crossref_primary_10_3389_fimmu_2021_746436 crossref_primary_10_3389_fimmu_2020_02194 crossref_primary_10_1146_annurev_immunol_101721_040259 crossref_primary_10_3389_fimmu_2023_1267697 crossref_primary_10_1016_j_smim_2021_101535 crossref_primary_10_1016_j_jconrel_2021_05_027 crossref_primary_10_1097_MED_0000000000000649 crossref_primary_10_3389_fimmu_2021_657768 crossref_primary_10_3390_vaccines12010071 crossref_primary_10_1111_imm_13241 crossref_primary_10_1186_s12951_021_00803_w crossref_primary_10_3389_fimmu_2022_864403 crossref_primary_10_1016_j_autrev_2023_103485 crossref_primary_10_3390_nano14010067 crossref_primary_10_1038_s41423_023_00989_z crossref_primary_10_1038_s41467_019_12902_2 crossref_primary_10_3389_fimmu_2020_00472 crossref_primary_10_1016_j_mbs_2023_108995 crossref_primary_10_3389_fimmu_2020_00633 crossref_primary_10_1016_j_jaut_2019_102328 crossref_primary_10_1039_D2MA00814A crossref_primary_10_1111_liv_15573 crossref_primary_10_3390_cells10030707 crossref_primary_10_1038_s41577_023_00970_x crossref_primary_10_1016_j_celrep_2021_108919 crossref_primary_10_1111_imcb_12439 crossref_primary_10_1016_j_nantod_2022_101694 crossref_primary_10_3389_fimmu_2020_575572 crossref_primary_10_1038_s41467_022_30759_w crossref_primary_10_1126_sciimmunol_aba0759 crossref_primary_10_1016_j_jtha_2022_09_002 crossref_primary_10_1126_sciadv_abb3116 crossref_primary_10_3389_fimmu_2021_814155 crossref_primary_10_1016_S2468_1253_20_30328_9 crossref_primary_10_3390_vaccines11061031 crossref_primary_10_3389_fendo_2021_622647 crossref_primary_10_1002_advs_202205105 crossref_primary_10_2217_nnm_2020_0102 crossref_primary_10_1016_j_berh_2024_101940 crossref_primary_10_1016_j_copbio_2021_12_012 crossref_primary_10_1016_j_biopha_2024_116702 crossref_primary_10_1038_s44222_022_00016_2 crossref_primary_10_1093_immadv_ltab009 crossref_primary_10_3389_fimmu_2021_684240 crossref_primary_10_1080_10717544_2022_2152136 crossref_primary_10_1166_sam_2023_4503 crossref_primary_10_1172_JCI130670 crossref_primary_10_1016_j_aohep_2019_09_009 crossref_primary_10_1080_00365521_2023_2278423 crossref_primary_10_3389_fbioe_2022_889291 crossref_primary_10_1016_j_coi_2021_03_019 crossref_primary_10_3389_fimmu_2022_1019339 crossref_primary_10_1016_j_apmt_2024_102278 crossref_primary_10_1016_j_cellimm_2020_104173 crossref_primary_10_3389_fimmu_2023_1177722 crossref_primary_10_1073_pnas_2110987119 crossref_primary_10_3389_fimmu_2020_01586 crossref_primary_10_1038_s41423_020_00568_6 crossref_primary_10_3389_fimmu_2021_681062 crossref_primary_10_1007_s40472_021_00325_2 crossref_primary_10_1097_HC9_0000000000000218 crossref_primary_10_1016_j_addr_2023_115140 crossref_primary_10_3389_fimmu_2023_1184252 |
Cites_doi | 10.1053/j.gastro.2005.12.029 10.1053/gast.2001.25542 10.1016/j.jhep.2014.02.006 10.1172/JCI4213 10.1002/hep.26380 10.1186/1465-9921-9-57 10.1136/gut.2007.122150 10.4049/jimmunol.181.10.6829 10.1016/j.jaut.2009.08.010 10.1016/j.jhep.2015.06.008 10.1034/j.1399-0039.2003.00152.x 10.1371/journal.pone.0079580 10.1038/nature16962 10.1016/j.coi.2005.09.014 10.3748/wjg.14.3781 10.1186/1740-2557-1-2 10.1016/0168-8278(95)80226-6 10.1056/NEJMra1506330 10.1055/s-0036-1597929 10.1046/j.1365-2168.2002.02183.x 10.4049/jimmunol.1202445 10.4049/jimmunol.1001597 10.1172/JCI0214698 10.1038/nnano.2017.56 10.1007/s12016-014-8427-x 10.1002/hep.20642 10.1053/j.gastro.2004.04.009 10.1084/jem.20051911 10.1002/hep.28641 |
ContentType | Journal Article |
Copyright | The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2019 |
Copyright_xml | – notice: The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2019 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PIMPY PQEST PQQKQ PQUKI PRINS RC3 SOI 5PM DOA |
DOI | 10.1038/s41467-019-09893-5 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management Health Research Premium Collection Natural Science Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts Technology Collection Technology Research Database ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) |
DatabaseTitleList | CrossRef MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 17 |
ExternalDocumentID | oai_doaj_org_article_d597958e29974428be28085b0fd4c0ca 10_1038_s41467_019_09893_5 31089130 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADRAZ AENEX AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU CGR CUY CVF DIK EBLON EBS ECM EE. EIF EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO NPM O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AAYXX CITATION 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PQEST PQUKI PRINS RC3 SOI 5PM |
ID | FETCH-LOGICAL-c562t-3064b2e4ee6059422808593e538fde5ade055da6c008717a8b506be04490f893 |
IEDL.DBID | RPM |
ISSN | 2041-1723 |
IngestDate | Fri Oct 04 13:13:27 EDT 2024 Tue Sep 17 21:24:17 EDT 2024 Fri Sep 13 08:48:07 EDT 2024 Fri Aug 23 00:39:54 EDT 2024 Sat Sep 28 08:25:48 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c562t-3064b2e4ee6059422808593e538fde5ade055da6c008717a8b506be04490f893 |
ORCID | 0000-0002-5413-9687 0000-0002-9867-2141 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517389/ |
PMID | 31089130 |
PQID | 2225129583 |
PQPubID | 546298 |
PageCount | 17 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d597958e29974428be28085b0fd4c0ca pubmedcentral_primary_oai_pubmedcentral_nih_gov_6517389 proquest_journals_2225129583 crossref_primary_10_1038_s41467_019_09893_5 pubmed_primary_31089130 |
PublicationCentury | 2000 |
PublicationDate | 2019-05-14 |
PublicationDateYYYYMMDD | 2019-05-14 |
PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-14 day: 14 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Nature communications |
PublicationTitleAlternate | Nat Commun |
PublicationYear | 2019 |
Publisher | Nature Publishing Group Nature Publishing Group UK Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group – name: Nature Publishing Group UK – name: Nature Portfolio |
References | K Zachou (9893_CR7) 2004; 1 MA Otten (9893_CR28) 2008; 181 X Clemente-Casares (9893_CR1) 2016; 530 S Shimoda (9893_CR12) 1998; 102 KN Lazaridis (9893_CR21) 2016; 375 EM de Vries (9893_CR26) 2015; 63 U Walter (9893_CR4) 2005; 17 IT Chow (9893_CR16) 2013; 190 EA te Velde (9893_CR29) 2002; 89 A Floreani (9893_CR8) 2015; 48 A Pares (9893_CR13) 2006; 130 J Irie (9893_CR9) 2006; 203 A Pares (9893_CR20) 2017; 37 MS Longhi (9893_CR18) 2010; 34 GX Yang (9893_CR23) 2011; 186 HR Bae (9893_CR14) 2016; 64 JR Hov (9893_CR6) 2008; 14 DE Jones (9893_CR5) 2008; 84 M Hardtke-Wolenski (9893_CR19) 2013; 58 K Ishak (9893_CR24) 1995; 22 MD Tate (9893_CR27) 2008; 9 P Fickert (9893_CR25) 2004; 127 H Kita (9893_CR11) 2002; 109 B Qin (9893_CR15) 2013; 8 P Fickert (9893_CR17) 2014; 60 P Fickert (9893_CR22) 2001; 121 AJ Robe (9893_CR10) 2005; 41 S Singha (9893_CR2) 2017; 12 S Lieberman (9893_CR3) 2003; 62 |
References_xml | – volume: 130 start-page: 715 year: 2006 ident: 9893_CR13 publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.12.029 contributor: fullname: A Pares – volume: 121 start-page: 170 year: 2001 ident: 9893_CR22 publication-title: Gastroenterology doi: 10.1053/gast.2001.25542 contributor: fullname: P Fickert – volume: 60 start-page: 1290 year: 2014 ident: 9893_CR17 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2014.02.006 contributor: fullname: P Fickert – volume: 102 start-page: 1831 year: 1998 ident: 9893_CR12 publication-title: J. Clin. Invest. doi: 10.1172/JCI4213 contributor: fullname: S Shimoda – volume: 58 start-page: 718 year: 2013 ident: 9893_CR19 publication-title: Hepatology doi: 10.1002/hep.26380 contributor: fullname: M Hardtke-Wolenski – volume: 9 start-page: 57 year: 2008 ident: 9893_CR27 publication-title: Respir. Res. doi: 10.1186/1465-9921-9-57 contributor: fullname: MD Tate – volume: 84 start-page: 23 year: 2008 ident: 9893_CR5 publication-title: Postgrad. Med. J. doi: 10.1136/gut.2007.122150 contributor: fullname: DE Jones – volume: 181 start-page: 6829 year: 2008 ident: 9893_CR28 publication-title: J. Immunol. doi: 10.4049/jimmunol.181.10.6829 contributor: fullname: MA Otten – volume: 34 start-page: 7 year: 2010 ident: 9893_CR18 publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2009.08.010 contributor: fullname: MS Longhi – volume: 63 start-page: 1212 year: 2015 ident: 9893_CR26 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.06.008 contributor: fullname: EM de Vries – volume: 62 start-page: 359 year: 2003 ident: 9893_CR3 publication-title: Tissue Antigens doi: 10.1034/j.1399-0039.2003.00152.x contributor: fullname: S Lieberman – volume: 8 start-page: e79580 year: 2013 ident: 9893_CR15 publication-title: PLoS ONE doi: 10.1371/journal.pone.0079580 contributor: fullname: B Qin – volume: 530 start-page: 434 year: 2016 ident: 9893_CR1 publication-title: Nature doi: 10.1038/nature16962 contributor: fullname: X Clemente-Casares – volume: 17 start-page: 624 year: 2005 ident: 9893_CR4 publication-title: Curr. Opin. Immunol. doi: 10.1016/j.coi.2005.09.014 contributor: fullname: U Walter – volume: 14 start-page: 3781 year: 2008 ident: 9893_CR6 publication-title: World J. Gastroenterol. doi: 10.3748/wjg.14.3781 contributor: fullname: JR Hov – volume: 1 start-page: 2 year: 2004 ident: 9893_CR7 publication-title: J. Autoimmune Dis. doi: 10.1186/1740-2557-1-2 contributor: fullname: K Zachou – volume: 22 start-page: 696 year: 1995 ident: 9893_CR24 publication-title: J. Hepatol. doi: 10.1016/0168-8278(95)80226-6 contributor: fullname: K Ishak – volume: 375 start-page: 2501 year: 2016 ident: 9893_CR21 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1506330 contributor: fullname: KN Lazaridis – volume: 37 start-page: 60 year: 2017 ident: 9893_CR20 publication-title: Semin. Liver Dis. doi: 10.1055/s-0036-1597929 contributor: fullname: A Pares – volume: 89 start-page: 1302 year: 2002 ident: 9893_CR29 publication-title: Br. J. Surg. doi: 10.1046/j.1365-2168.2002.02183.x contributor: fullname: EA te Velde – volume: 190 start-page: 4516 year: 2013 ident: 9893_CR16 publication-title: J. Immunol. doi: 10.4049/jimmunol.1202445 contributor: fullname: IT Chow – volume: 186 start-page: 1259 year: 2011 ident: 9893_CR23 publication-title: J. Immunol. doi: 10.4049/jimmunol.1001597 contributor: fullname: GX Yang – volume: 109 start-page: 1231 year: 2002 ident: 9893_CR11 publication-title: J. Clin. Invest. doi: 10.1172/JCI0214698 contributor: fullname: H Kita – volume: 12 start-page: 701 year: 2017 ident: 9893_CR2 publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2017.56 contributor: fullname: S Singha – volume: 48 start-page: 192 year: 2015 ident: 9893_CR8 publication-title: Clin. Rev. Allergy Immunol. doi: 10.1007/s12016-014-8427-x contributor: fullname: A Floreani – volume: 41 start-page: 1106 year: 2005 ident: 9893_CR10 publication-title: Hepatology doi: 10.1002/hep.20642 contributor: fullname: AJ Robe – volume: 127 start-page: 261 year: 2004 ident: 9893_CR25 publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.04.009 contributor: fullname: P Fickert – volume: 203 start-page: 1209 year: 2006 ident: 9893_CR9 publication-title: J. Exp. Med. doi: 10.1084/jem.20051911 contributor: fullname: J Irie – volume: 64 start-page: 1189 year: 2016 ident: 9893_CR14 publication-title: Hepatology doi: 10.1002/hep.28641 contributor: fullname: HR Bae |
SSID | ssj0000391844 |
Score | 2.5691137 |
Snippet | Peptide-major histocompatibility complex class II (pMHCII)-based nanomedicines displaying tissue-specific autoantigenic epitopes can blunt specific autoimmune... Abstract Peptide-major histocompatibility complex class II (pMHCII)-based nanomedicines displaying tissue-specific autoantigenic epitopes can blunt specific... Immune response against tissue-specific antigens is a hallmark of autoimmunity. Here the authors show that a single autoantigen-based nanomedicine can... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 2150 |
SubjectTerms | Aged Animal models Animals Antigens Autoantigens Autoantigens - immunology Autoimmune diseases Autoimmune Diseases - drug therapy Autoimmune Diseases - immunology CD4 antigen Cell Line Cholangitis Dendritic cells Disease Disease Models, Animal Drainage Endoplasmic reticulum Epitopes Epitopes - immunology Female Hepatitis Hepatocytes Histocompatibility Antigens Class II - chemistry Histocompatibility Antigens Class II - immunology Humans Immunity Inflammation Kupffer cells Liver Liver - drug effects Liver - immunology Liver diseases Liver Diseases - drug therapy Liver Diseases - immunology Lymph nodes Lymphocytes B Lymphocytes T Major histocompatibility complex Male Manufacturing cells Metastases Mice Middle Aged Mitochondria Nanomedicine - methods Nanoparticles - administration & dosage Nanoparticles - chemistry Peptides Peptides - administration & dosage Peptides - chemistry Peptides - immunology T-Lymphocytes, Regulatory - drug effects T-Lymphocytes, Regulatory - immunology Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOilpG-nadGhtyIi25ItHZPQsBTSUwq5CT3GdCGxQ3b3kH-fGckbdkugl15lg8U345lvpHkw9s32wUfVg2jqYRDKaylCH2vRJzCDNaophzmXv7rFb_XzWl_vjPqinLDSHrgAd5KQ8VptAM1mr5ArB2gM0oQgh6SijIUa1XonmMo2uLUYuqi5Ska25mSlsk2QVLNj0UkLveeJcsP-51jm38mSO97n4pC9nmkjPy3bfcNewPiWvSyDJB_esSUN5ywZrSOfBu55uJ984rmO8n5zS2s3lIHB_WY9LakmBDgNI86mD1Y8PHA6NLjBVUpzSSAuF-eCXFziox-n7RX86j27uvhxdb4Q8xAFEZHarAVFGKEBBdBRa5Ymo2dbQEM3JNA-gdQ6-S5Sc7q69yZo2QWQSlk5IE4f2ME4jfCJcWUb30YbMaJslQEVLHS1DzHppPzQ2op93-Lp7kqrDJevuFvjCvoO0XcZfacrdkaQP71Jba7zAgrfzcJ3_xJ-xY63AnPzv7dyFMEii9GmrdjHIrunryCZpXtZWbF-T6p729h_Mi7_5K7bna57ZHdH_2Pfn9mrJmuiFrU6ZgeoCfAFyc06fM16_Ajem_ay priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LaxRBEC5iguBFfLsxSh-8SbM9M9XzOIkJCYuQIBIht6YfNboQZ-Lu5pB_n66emdUV8doz0E1Vd73rK4D3TeWsx4pknrWtRKuVdJXPZBWobpsa8yGYc35RLr7h5yt9tQeLqReGyyonmZgEdeg9x8jn7JdE3aTrYm4dRwH8Zv7x5pfk-VGcZx2HaTyAgzxDTtgeHJ9efPm6jbcwEnqNOPbNqKKerzFJCcVdPE1U21Lv6KYE4f8vu_Pv8sk_9NHZE3g8GpLi08D5p7BH3TN4OIyWvHsOSx7XOdS4dqJvhRVu1dsgUmfl6vYnr11zTYawt5t-yV0iJHg8cRKGtBbuTnAY4TqucuFLIHm-OJGs9ILobNdPSfn1C7g8O708WchxrIL00djZSPY5XE5IVDJYC-PhMOgZRdHXBtI2kNI62NIzXF1W2dppVTpSiI1qI51ewn7Xd_QaBDa5LXzjo49ZYE3oGioz63zQAW1bNDP4MNHT3AzgGSYlvYvaDNQ3kfomUd_oGRwzybd_MvB1WuhX3834jkyIDlC8BBS1aIXRdXKUju9UG9Arb2dwNDHMjK9xbX7fnRm8Gni33SWat5ypVTOodri6c4zdL93yR8LhLnVWRXvv8P9bvoFHebpjWmZ4BPuRx_Q2GjIb9268o_e2wvPK priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB6VIiQuiHdTCvKBGzI4iZ3EB4RKRbVCWk6t1JvlxwRWWhK6u5XYf1-Pk1RdtOLqJLI1M_Z8E898A_Be1856WSMv8rbl0irBXe1zXgdsWt3IYviZM_9RzS7l9yt1dQBTu6NRgOu9oR31k7pcLT_-vd5-iRv-81Ay3nxay7TdBZXj6Oh_uXoADwtZSrL4-Qj308lc6hjQyLF2Zv-nO_4p0fjvw57_plDe80nnT-HJCCbZ6aD9Z3CA3XN4NLSX3L6ABbXsHPJcO9a3zDK36m1gqbpydfObxpaUl8HszaZfUKUIMmpRnA5EXDO3ZfQrYRlHKfklIJ_Pzjg5vsA62_XTxfz6JVycf7s4m_GxtQL3EfBsOMUdrkCJWBFhC3HiEPEZxuOvDahsQKFUsJUnyrq8to1TonIopNSijXJ6BYdd3-ERMKkLW3rtY5xZygal01jl1vmggrRtqTP4MMnT_BkINEy6-C4bM0jfROmbJH2jMvhKIr97k8iv00C_-mnGvWRCDIK0ajB60lrG8MlhWr4TbZBeeJvByaQwMxmUobg2YhvVlBm8HnR3N0uEuHRbKzKod7S6s4zdJ93iV-LirlReR8x3_P8p38DjItmY4rk8gcOoY3wbwczGvUsWegugmPHx priority: 102 providerName: Scholars Portal |
Title | Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31089130 https://www.proquest.com/docview/2225129583/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC6517389 https://doaj.org/article/d597958e29974428be28085b0fd4c0ca |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFBdtx2CXse-67YIOuw01cixZ0jENzUIgpWwd5Cb05S2Q2CVJD_3v9yTbpRk77SKDbGOh37Pee9J7v4fQFyWscUwEMsqrijDDKbHC5UT4ICsl2ajdzFnclLOfbL7kyyPE-1yYFLTv7OqyXm8u69XvFFt5v3HDPk5seLuYlDwXoGiHx-hYFMUzFz0tv4UCr4V1CTK0kMMdS8sBjek6CvQzieVqwKyJJ3T0QB8l2v5_2Zp_h0w-00HTN-h1ZzzicTvIt-go1O_Qy7ac5ON7tIolOtu41ho3FTbYbhvjccqm3D5sYt86xmFg87BvVjEzJOBYkjgtgGGH7SOOWwdr6I3BLj6QxWxCoqLzuDZ10x_E7z6gu-n13WRGulIKxIGBsyfRz7CjwEIoI0FL5MCJRGcBlrvKB258oJx7U7pIUZcLIy2npQ2UMUUrmLKP6KRu6nCKMFMjUzjlwK8smAzMqlDmxjrPPTNVoTL0tZ9Pfd8SZuh00F1I3QKhAQidgNA8Q1dxyp-ejGTXqaPZ_tId5NqD06O4DKA5BQN3yYY0fEsrzxx1JkMXPWC6-wN3OvqxYMtwWWToU4vd01d67DMkDlA9GMbhHRDFxL3did7Zf795jl6NkiRykrMLdALwh89g1-ztAKR5KaCV028D9GI8nv-Yw_Xq-ub2-yDtFUC7YHKQ5P0PZK_-cg |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,12792,21416,24346,27957,27958,31754,33408,33779,43345,43635,43840,53827,53829,74102,74392,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMEF8SalgA_ckFUnGcfJCUFFtUC3p0Xam-XHBFYqSdlsD_339TjZhUWIqxPJ1ow97_mGsbeNdtaDRlHkbSvAKimc9rnQAeu2qaEYgznz82r2Db4s1XIKuA1TWeVWJiZBHXpPMfJj8kuiblJ1-f7yl6CpUZRdnUZo3GZ3oCyBSvr0Uu9iLIR-XgNMvTKyrI8HSJJBUudOE1W1UHv6KMH2_8vW_Ltk8g8ddPqQPZiMR_5h5PYjdgu7x-zuOE7y-glb0YjOsa61433LLXfr3gaeuinXVz9p7YLqMLi92vQr6gxBTiOJkwDEgbtrTqGDi7hKxS4BxXx2IkjRBd7Zrt8m4oenbHH6aXEyE9MoBeGjgbMR5Ge4AgGxIoAWwsAhoDOM4q4NqGxAqVSwlSeIulzb2ilZOZQAjWwjnZ6xg67v8AXj0BS29I2PfmUJNYJrsMqt80EFsG3ZZOzdlp7mcgTMMCnRXdZmpL6J1DeJ-kZl7CORfPcngV2nhX793Uxvx4To9ETGY9ScGqK75DAd38k2gJfeZuxoyzAzvcDB_L4vGXs-8m63SzRpKTsrM6b3uLp3jP0v3epHwt6uVK6jjXf4_y3fsHuzxfzMnH0-__qS3S_SfVMihyN2EPmNr6Ihs3Gv0229AYvu8Zc |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMQF8SZQwAduyFonsePkhKCwWh6tOBRpb5Yf47JSScpme-i_x-N4FxYhrk4kWzPjeXnmG0JedcoaJxSwqgyBCSM5s8qVTHloQ9eKakrmHJ80i2_i01Iuc_3TmMsqtzoxKWo_OMyRzzAuibZJtvUs5LKIr-_nby5-MpwghS-teZzGdXIjWkmO0wzUUu3yLYiE3gqR-2Z43c5GkbQExy6eLpptJvdsU4Lw_5ff-Xf55B_2aH6X3MmOJH07cf4euQb9fXJzGi159YCscFznVOPa0yFQQ-16MJ6mzsr15Q9cO8eaDGouN8MKu0SA4njipAxhpPaKYhrhPK5i4YsHdrw4Ymj0PO1NP2wf5ceH5HT-4fRowfJYBeais7NhGHPYCgRAg2AtiIeDoGcQVV_wII0HLqU3jUO4ulKZ1kreWOBCdDxEOj0iB_3QwxNCRVeZ2nUuxpi1aEHYDprSWOelFybUXUFeb-mpLybwDJ0evetWT9TXkfo6UV_LgrxDku_-RODrtDCsz3S-R9rHACgKAUQrqkQMnSyk41sevHDcmYIcbhmm820c9W_ZKcjjiXe7XaJ7iy-1vCBqj6t7x9j_0q--JxzuRpYq-ntP_7_lS3IrCqr-8vHk8zNyu0riJlkpDslBZDc8jz7Nxr5IwvoLtQj1ww |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Suppression+of+a+broad+spectrum+of+liver+autoimmune+pathologies+by+single+peptide-MHC-based+nanomedicines&rft.jtitle=Nature+communications&rft.au=Umeshappa+Channakeshava+Sokke&rft.au=Singha+Santiswarup&rft.au=Blanco%2C+Jesus&rft.au=Shao+Kun&rft.date=2019-05-14&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=10&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-019-09893-5&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |